NUVL
Nuvalent, Inc.Company with tickers: NUVL
CIK
1861560
CUSIP
670703107
Shares Outstanding
73,181,747
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-01 | Balcom Alexandra | Chief Financial Officer | Convert | 11,430 |
| 2026-04-01 | Balcom Alexandra | Chief Financial Officer | Sell | 3,544 |
| 2026-04-01 | Balcom Alexandra | Chief Financial Officer | Convert | 11,430 |
| 2026-04-01 | Lane Benjamin | See Remarks | Award | 19,000 |
| 2026-04-01 | Lane Benjamin | See Remarks | Award | 9,500 |
| 2026-03-30 | Noci Darlene | Chief Development Officer | Sell | 2,532 |
| 2026-03-30 | Noci Darlene | Chief Development Officer | Convert | 5,500 |
| 2026-03-30 | Noci Darlene | Chief Development Officer | Convert | 5,500 |
| 2026-03-26 | Miller Deborah Ann | Chief Legal Officer | Sell | 940 |
| 2026-03-26 | Miller Deborah Ann | Chief Legal Officer | Convert | 5,500 |
| 2026-03-26 | Miller Deborah Ann | Chief Legal Officer | Convert | 5,500 |
| 2026-03-25 | Balcom Alexandra | Chief Financial Officer | Sell | 13,700 |
| 2026-03-24 | Balcom Alexandra | Chief Financial Officer | Sell | 2,599 |
| 2026-03-24 | Balcom Alexandra | Chief Financial Officer | Convert | 11,430 |
| 2026-03-24 | Balcom Alexandra | Chief Financial Officer | Convert | 11,430 |
| 2026-03-16 | Lane Benjamin | See Remarks | Other | 0 |
| 2026-03-16 | Lane Benjamin | See Remarks | Other | 40,868 |
| 2026-03-13 | Pelish Henry E. | Chief Scientific Officer | Sell | 804 |
| 2026-03-12 | Pelish Henry E. | Chief Scientific Officer | Convert | 8,456 |
| 2026-03-12 | Pelish Henry E. | Chief Scientific Officer | Sell | 24,189 |
| 2026-03-12 | Pelish Henry E. | Chief Scientific Officer | Convert | 8,456 |
| 2026-03-06 | Porter James Richard | Director, President and CEO | Convert | 30,000 |
| 2026-03-06 | Porter James Richard | Director, President and CEO | Convert | 30,000 |
| 2026-03-06 | Porter James Richard | Director, President and CEO | Sell | 13,585 |
| 2026-02-26 | Miller Deborah Ann | Chief Legal Officer | Convert | 5,500 |
| 2026-02-26 | Miller Deborah Ann | Chief Legal Officer | Sell | 2,698 |
| 2026-02-26 | Miller Deborah Ann | Chief Legal Officer | Convert | 5,500 |
| 2026-02-26 | Noci Darlene | Chief Development Officer | Convert | 5,500 |
| 2026-02-26 | Noci Darlene | Chief Development Officer | Convert | 5,500 |
| 2026-02-26 | Noci Darlene | Chief Development Officer | Sell | 3,000 |
| 2026-01-29 | Noci Darlene | Chief Development Officer | Convert | 5,500 |
| 2026-01-29 | Noci Darlene | Chief Development Officer | Convert | 5,500 |
| 2026-01-29 | Noci Darlene | Chief Development Officer | Sell | 189 |
| 2026-01-22 | Miller Deborah Ann | Chief Legal Officer | Sell | 14,300 |
| 2026-01-22 | Miller Deborah Ann | Chief Legal Officer | Convert | 14,300 |
| 2026-01-22 | Miller Deborah Ann | Chief Legal Officer | Convert | 14,300 |
| 2026-01-21 | Miller Deborah Ann | Chief Legal Officer | Convert | 700 |
| 2026-01-21 | Miller Deborah Ann | Chief Legal Officer | Sell | 700 |
| 2026-01-21 | Miller Deborah Ann | Chief Legal Officer | Convert | 700 |
| 2026-01-07 | Pelish Henry E. | Chief Scientific Officer | Award | 17,500 |
| 2026-01-07 | Pelish Henry E. | Chief Scientific Officer | Award | 17,500 |
| 2026-01-07 | Noci Darlene | Chief Development Officer | Award | 17,500 |
| 2026-01-07 | Noci Darlene | Chief Development Officer | Award | 17,500 |
| 2026-01-07 | Miller Deborah Ann | Chief Legal Officer | Award | 17,500 |
| 2026-01-07 | Miller Deborah Ann | Chief Legal Officer | Award | 17,500 |
| 2026-01-07 | Turner Christopher Durant | Chief Medical Officer | Award | 17,500 |
| 2026-01-07 | Turner Christopher Durant | Chief Medical Officer | Award | 17,500 |
| 2026-01-07 | Porter James Richard | Director, President and CEO | Award | 46,250 |
| 2026-01-07 | Porter James Richard | Director, President and CEO | Award | 46,250 |
| 2026-01-07 | Balcom Alexandra | Chief Financial Officer | Award | 17,500 |
| 2026-01-07 | Balcom Alexandra | Chief Financial Officer | Award | 17,500 |
| 2026-01-06 | Pelish Henry E. | Chief Scientific Officer | Sell | 1,106 |
| 2026-01-06 | Noci Darlene | Chief Development Officer | Sell | 1,321 |
| 2026-01-06 | Miller Deborah Ann | Chief Legal Officer | Sell | 1,075 |
| 2026-01-06 | Turner Christopher Durant | Chief Medical Officer | Sell | 1,321 |
| 2026-01-06 | Porter James Richard | Director, President and CEO | Sell | 3,963 |
| 2026-01-06 | Balcom Alexandra | Chief Financial Officer | Sell | 1,321 |
| 2026-01-05 | Pelish Henry E. | Chief Scientific Officer | Sell | 513 |
| 2026-01-05 | Noci Darlene | Chief Development Officer | Sell | 871 |
| 2026-01-05 | Miller Deborah Ann | Chief Legal Officer | Sell | 897 |
| 2026-01-05 | Turner Christopher Durant | Chief Medical Officer | Sell | 871 |
| 2026-01-05 | Porter James Richard | Director, President and CEO | Sell | 3,679 |
| 2026-01-05 | Balcom Alexandra | Chief Financial Officer | Sell | 871 |
| 2026-01-02 | Miller Deborah Ann | Chief Legal Officer | Convert | 10,000 |
| 2026-01-02 | Miller Deborah Ann | Chief Legal Officer | Sell | 4,005 |
| 2026-01-02 | Miller Deborah Ann | Chief Legal Officer | Convert | 10,000 |
| 2025-12-30 | Noci Darlene | Chief Development Officer | Convert | 4,000 |
| 2025-12-30 | Noci Darlene | Chief Development Officer | Convert | 4,000 |
| 2025-12-30 | Noci Darlene | Chief Development Officer | Sell | 3,358 |
| 2025-12-22 | Pelish Henry E. | Chief Scientific Officer | Convert | 5,085 |
| 2025-12-22 | Pelish Henry E. | Chief Scientific Officer | Convert | 5,085 |
| 2025-12-22 | Balcom Alexandra | Chief Financial Officer | Convert | 34,500 |
| 2025-12-22 | Balcom Alexandra | Chief Financial Officer | Convert | 34,500 |
| 2025-12-19 | Porter James Richard | Director, President and CEO | Convert | 57,000 |
| 2025-12-19 | Porter James Richard | Director, President and CEO | Convert | 57,000 |
| 2025-12-10 | Squarer Ron | Director | Award | 2,837 |
| 2025-12-10 | Squarer Ron | Director | Award | 4,418 |
| 2025-12-10 | Squarer Ron | Director | Other | 0 |
| 2025-12-08 | Balcom Alexandra | Chief Financial Officer | Sell | 6,984 |
| 2025-11-28 | Noci Darlene | Chief Development Officer | Sell | 645 |
| 2025-11-28 | Noci Darlene | Chief Development Officer | Convert | 4,000 |
| 2025-11-28 | Noci Darlene | Chief Development Officer | Convert | 4,000 |
| 2025-11-24 | Shair Matthew | Director | Sell | 369 |
| 2025-11-24 | Flynn James E | 10% Owner | Sell | 371,287 |
| 2025-11-24 | Flynn James E | 10% Owner | Other | 650,000 |
| 2025-11-18 | Balcom Alexandra | Chief Financial Officer | Sell | 220 |
| 2025-11-18 | Balcom Alexandra | Chief Financial Officer | Convert | 729 |
| 2025-11-18 | Balcom Alexandra | Chief Financial Officer | Convert | 729 |
| 2025-11-17 | Balcom Alexandra | Chief Financial Officer | Convert | 6,875 |
| 2025-11-17 | Balcom Alexandra | Chief Financial Officer | Convert | 6,875 |
| 2025-11-17 | Balcom Alexandra | Chief Financial Officer | Sell | 3,609 |
| 2025-11-17 | Miller Deborah Ann | Chief Legal Officer | Sell | 15,075 |
| 2025-11-17 | Miller Deborah Ann | Chief Legal Officer | Convert | 24,200 |
| 2025-11-17 | Miller Deborah Ann | Chief Legal Officer | Convert | 24,200 |
| 2025-10-30 | Noci Darlene | Chief Development Officer | Sell | 57 |
| 2025-10-30 | Noci Darlene | Chief Development Officer | Convert | 4,000 |
| 2025-10-30 | Noci Darlene | Chief Development Officer | Convert | 4,000 |
| 2025-10-30 | Miller Deborah Ann | Chief Legal Officer | Sell | 700 |
| 2025-10-30 | Miller Deborah Ann | Chief Legal Officer | Convert | 21,800 |
| 2025-10-30 | Miller Deborah Ann | Chief Legal Officer | Convert | 21,800 |